Cargando…

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules

Immunosenescence is characterised by reduced B and T cell responses. Evidence shows that booster vaccinations are less effective in elderly people, but data on the efficacy of primary immunisation are sparse. We conducted a monocentric, open label, phase IV trial to compare immune responses to prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Angelika, Garner-Spitzer, Erika, Jasinska, Joanna, Kollaritsch, Herwig, Stiasny, Karin, Kundi, Michael, Wiedermann, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026142/ https://www.ncbi.nlm.nih.gov/pubmed/29959387 http://dx.doi.org/10.1038/s41598-018-28111-8

Ejemplares similares

Obesity and Sex Affect the Immune Responses to Tick-Borne Encephalitis Booster Vaccination
por: Garner-Spitzer, Erika, et al.
Publicado: (2020)

Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022
por: Wagner, Angelika, et al.
Publicado: (2023)

Primary vaccine failure to routine vaccines: Why and what to do?
por: Wiedermann, Ursula, et al.
Publicado: (2016)

Machine Learning-Empowered FTIR Spectroscopy Serum Analysis Stratifies Healthy, Allergic, and SIT-Treated Mice and Humans
por: Korb, Elke, et al.
Publicado: (2020)

Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
por: Angelika, Wagner, et al.
Publicado: (2022)

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.
por: Wagner, Angelika, et al.
Publicado: (2022)

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017)

Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments
por: Wagner, Angelika, et al.
Publicado: (2021)

Adherence to the paediatric immunisation schedule in England
por: Bauwens, Jorgen, et al.
Publicado: (2021)

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021)

Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
por: Richter, Lukas, et al.
Publicado: (2019)

Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
por: Richter, Lukas, et al.
Publicado: (2019)

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
por: Garner-Spitzer, Erika, et al.
Publicado: (2022)

Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model
por: Tobias, Joshua, et al.
Publicado: (2022)

Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice
por: King, Deborah F. L., et al.
Publicado: (2015)

Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer
por: Tobias, Joshua, et al.
Publicado: (2022)

The UK immunisation schedule: changes to vaccine policy and practice in 2013/14
por: Atchison, Christina J, et al.
Publicado: (2015)

Prime-Boost Vaccination with Toxoplasma Lysate Antigen, but Not with a Mixture of Recombinant Protein Antigens, Leads to Reduction of Brain Cyst Formation in BALB/c Mice
por: Wagner, Angelika, et al.
Publicado: (2015)

Oocyst-Derived Extract of Toxoplasma Gondii Serves as Potent Immunomodulator in a Mouse Model of Birch Pollen Allergy
por: Wagner, Angelika, et al.
Publicado: (2016)

Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses
por: Wernsdorfer, Walther H, et al.
Publicado: (2013)

Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers
por: Ede, Nicholas J., et al.
Publicado: (2022)

Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule
por: Bauwens, Jorgen, et al.
Publicado: (2021)

Prevention of Birch Pollen-Related Food Allergy by Mucosal Treatment with Multi-Allergen-Chimers in Mice
por: Hoflehner, Elisabeth, et al.
Publicado: (2012)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation
por: Garner-Spitzer, Erika, et al.
Publicado: (2023)

A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors
por: Tobias, Joshua, et al.
Publicado: (2020)

Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease
por: Wagner, Angelika, et al.
Publicado: (2022)

Genetic Variation of Bordetella pertussis in Austria
por: Wagner, Birgit, et al.
Publicado: (2015)

Vaccination against Her-2/neu, with focus on peptide-based vaccines
por: Tobias, J., et al.
Publicado: (2022)

Cellular and Humoral Immune Responses after Immunisation with Low Virulent African Swine Fever Virus in the Large White Inbred Babraham Line and Outbred Domestic Pigs
por: Goatley, Lynnette C., et al.
Publicado: (2022)

Measles Immunisation
Publicado: (1929)

Immunisation in pregnancy
por: Lim, Boon H.
Publicado: (2021)

The Role of Alveolar Epithelial Type II-Like Cells in Uptake of Structurally Different Antigens and in Polarisation of Local Immune Responses
por: Akgün, Johnnie, et al.
Publicado: (2015)

Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
por: Totterdell, James A., et al.
Publicado: (2022)

Why are missed opportunities for immunisation and immunisation defaulting among children indistinguishable?
por: Idris, Israel Oluwaseyidayo, et al.
Publicado: (2022)

A novel approach to evaluating the UK childhood immunisation schedule: estimating the effective coverage vector across the entire vaccine programme
por: Crowe, Sonya, et al.
Publicado: (2015)

Recent Reverses in Immunisation
por: McLeod, W. J.
Publicado: (1951)

A Curiosity of Immunisation
Publicado: (1905)

Immunisation against Measles
Publicado: (1919)

Cannot write session to /tmp/vufind_sessions/sess_spmb1i3j14adf2lkcofri4638f